Bottom line
RSPH vs SWHFX: the short answer
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and SWHFX (Schwab Health Care Fund) are both etfs.
RSPH is cheaper at 0.4% vs 0.8% — a difference of $40 a year per $10,000 invested.
Over five years, SWHFX returned +6.5% a year vs +4.7% for RSPH.
Updated Nov 19, 2026
RSPH vs SWHFX side by side
| RSPH | SWHFX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Invesco | Schwab |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.4% | 0.8% |
| Annual cost per $10k | $40 | $80 |
| 10-yr cost on $10k (prospectus) | $505 | $990 |
| Max front load | None | — |
| 12b-1 fee | — | 0% |
| 1-yr return | +9.3% | +15.9% |
| 5-yr return (annualized) | +4.7% | +6.5% |
| 10-yr return (annualized) | +8.2% | +8.1% |
| Best quarter | +17.5% | +15.3% |
| Worst quarter | −14.3% | −12.1% |
| Net assets (fund) | $766.9M | $642.3M |
| Number of holdings | 63 | 80 |
| Portfolio turnover | 24% | 41% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RSPH | SWHFX | Difference |
|---|---|---|---|
| 2025 | +9.3% | +15.9% | −6.6% |
| 2024 | −0.8% | +0.1% | −0.9% |
| 2023 | +3.9% | +0.7% | +3.3% |
| 2022 | −9.2% | −4.7% | −4.6% |
| 2021 | +23.0% | +23.3% | −0.3% |
| 2020 | +18.9% | +12.9% | +6.1% |
| 2019 | +25.3% | +17.6% | +7.7% |
| 2018 | −0.3% | +4.0% | −4.3% |
| 2017 | +23.4% | +20.2% | +3.2% |
| 2016 | −4.5% | −4.4% | −0.2% |
Source: Fund prospectus bar charts
Holdings overlap
7 of RSPH's top 25 holdings also appear in SWHFX's top 25.
| Holding | RSPH | SWHFX |
|---|---|---|
| Thermo Fisher Scientific Inc. | 1.84% | 2.16% |
| Abbott Laboratories | 1.83% | 1.60% |
| Bristol-Myers Squibb Co. | 1.82% | 2.44% |
| Amgen Inc. | 1.77% | 2.58% |
| Incyte Corp. | 1.76% | 1.37% |
| Becton, Dickinson and Co. | 1.73% | 1.24% |
| AbbVie Inc. | 1.73% | 5.81% |
Source: SEC Form N-PORT
RSPH top 10
- Bio-Techne Corp. — 2.13%
- IQVIA Holdings Inc. — 2.00%
- Baxter International Inc. — 1.99%
- Regeneron Pharmaceuticals, Inc. — 1.96%
- Mettler-Toledo International Inc. — 1.94%
- Charles River Laboratories International, Inc. — 1.93%
- Veeva Systems Inc. — 1.93%
- DaVita Inc. — 1.87%
- Moderna, Inc. — 1.85%
- Thermo Fisher Scientific Inc. — 1.84%
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
FAQ
What is the difference between RSPH and SWHFX?
Which is cheaper, RSPH or SWHFX?
Should I own both RSPH and SWHFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.